{"id":50218,"date":"2019-07-17T00:00:00","date_gmt":"2019-07-16T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/"},"modified":"2019-07-17T00:00:00","modified_gmt":"2019-07-16T23:00:00","slug":"eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/","title":{"rendered":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign"},"content":{"rendered":"

Senolytic Therapeutics and Morai Biodesign, headquartered in the Barcelona Science Park,\u00a0are two of the 15 awarded Spanish start-ups in the 2019\u00a0EIT Health Headstart Programme<\/a>\u00a0to accelerate their time-to-market, that\u00a0includes funding, mentoring and networking opportunities.<\/p>\n

Moirai Biodesign<\/a>\u00a0is a biotech start-up that develops Kloto-DX, a near-patient, end-to-end, low-cost and fast molecular diagnostics platform. This next generation diagnostic tool is built upon their Plug and Play RNA technology, a family of programmable biosensors capable of detecting low concentrations of different biomarkers from a patient\u2019s blood sample. The first kit they are developing for the Kloto-DX diagnostics platform is focused at the determination of the aetiology of sepsis. The kit will allow identification of the most important sepsis-causing pathogens and their associated antibiotic resistances, at the point of care and directly from the patient’s blood, in just three hours.<\/p>\n

Senolytic Therapeutics<\/a>\u00a0develops novel classes of medicines that target and eliminate damaged (senescent) cells. Their mission is to advance a portfolio of therapies to clinical trials and improve the lives of those affected by diseases associated with ageing. They have developed a unique technological portfolio that is based on drug therapies that eliminate senescent in age-related diseases. The development of therapies to specifically inhibit PD-L2 in damaged cells results in the improvement in the outcomes of diseases associated with these types of cells.,<\/p>\n

\u201cWe are delighted to support these early stage companies in their journey to develop global health solutions,\u201d said Irene S\u00e1nchez, Business Creation Manager at EIT Health Spain. \u201cThe high quality of the applications received this year clearly shows that innovative and entrepreneurship culture are firmly rooted and speeding up in Spain.\u201d<\/p>\n

The\u00a0EIT Health Headstart Programme\u00a0provides funding of up to \u20ac50\u00a0000 to support early stage companies and SMEs in developing new products and services. Selected companies will work on their product launch project with support from the regional managers to access local and EIT Health networks. The programme seeks to help entrepreneurs shorten time-to-market for innovative products and services; to verify the need and\/or benefit of the solution for users, customers, payers, and partners; and to increase the possibility of attracting further investment.<\/p>\n

The three areas of the innovation triangle: research, education and business creation<\/strong><\/p>\n

EIT Health Spain\u00a0is\u00a0the Spanish node of EIT Health<\/a>, the Knowledge and Innovation Community (KIC<\/a>),\u00a0dedicated to healthy living and active aging and promoted by the European Institute of Technology and Innovation (EIT<\/a>). Based in the Barcelona Science Park (PCB), the consortium currently brings together 18 leading public\u00a0and private entities in the three areas of the innovation triangle: research, education and business creation.<\/p>\n

Since 2016, EIT Health supported more than 100 Spanish start-ups through a variety of acceleration programmes designed to support healthcare entrepreneurs at every stage of their business journey. Only in 2019, EIT Health will contribute more than \u20ac1 million to the Spanish health entrepreneurship ecosystem.<\/p>\n

\u25ba More information: EIT Health Spain website\u00a0[+]<\/a><\/strong><\/p>\n

\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

EIT Health Spain<\/a> has announced today the 15 Spanish start-ups selected for 2019 Headstart Programe, which includes funding, mentoring and networking opportunities. Among those selected are Senolytic Therapeutics and Moirai Biodesign based in the Barcelona Science Park. Since 2016 the Spanish node of\u00a0EIT Health<\/a>, located in the Park, has supported more than 100 Spanish start-ups through a variety of acceleration programmes designed to support healthcare entrepreneurs at every stage of their business journey.<\/p>\n

\u00a0<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-50218","post","type-post","status-publish","format-standard","category-uncategorized"],"acf":[],"yoast_head":"\nEIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"EIT Health Spain has announced today the 15 Spanish start-ups selected for 2019 Headstart Programe, which includes funding, mentoring and networking opportunities. Among those selected are Senolytic Therapeutics and Moirai Biodesign based in the Barcelona Science Park. Since 2016 the Spanish node of\u00a0EIT Health, located in the Park, has supported more than 100 Spanish start-ups through a variety of acceleration programmes designed to support healthcare entrepreneurs at every stage of their business journey. \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2019-07-16T23:00:00+00:00\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign\",\"datePublished\":\"2019-07-16T23:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/\"},\"wordCount\":492,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/\",\"name\":\"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"datePublished\":\"2019-07-16T23:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/en\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/","og_locale":"en_US","og_type":"article","og_title":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona","og_description":"EIT Health Spain has announced today the 15 Spanish start-ups selected for 2019 Headstart Programe, which includes funding, mentoring and networking opportunities. Among those selected are Senolytic Therapeutics and Moirai Biodesign based in the Barcelona Science Park. Since 2016 the Spanish node of\u00a0EIT Health, located in the Park, has supported more than 100 Spanish start-ups through a variety of acceleration programmes designed to support healthcare entrepreneurs at every stage of their business journey. \u00a0","og_url":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2019-07-16T23:00:00+00:00","author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Written by":"adminpcb","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign","datePublished":"2019-07-16T23:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/"},"wordCount":492,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/","url":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/","name":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"datePublished":"2019-07-16T23:00:00+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/en\/eit-health-spain-awards-headstart-programme-support-to-senolytic-therapeutics-and-moirai-biodesign\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/en\/"},{"@type":"ListItem","position":2,"name":"EIT Health Spain awards Headstart Programme support to Senolytic Therapeutics and Moirai Biodesign"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/en\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/50218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/comments?post=50218"}],"version-history":[{"count":0,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/posts\/50218\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/media?parent=50218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/categories?post=50218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/en\/wp-json\/wp\/v2\/tags?post=50218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}